Noxopharm Ltd
ASX:NOX
Income Statement
Earnings Waterfall
Noxopharm Ltd
Income Statement
Noxopharm Ltd
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
3
N/A
|
4
+14%
|
4
+10%
|
8
+92%
|
6
-30%
|
6
-2%
|
6
+9%
|
5
-13%
|
7
+29%
|
6
-13%
|
4
-36%
|
2
-38%
|
2
-2%
|
3
+20%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(13)
|
(16)
|
(18)
|
(16)
|
(14)
|
(20)
|
(19)
|
(15)
|
(18)
|
(17)
|
(11)
|
(7)
|
(7)
|
(8)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(11)
|
(9)
|
(7)
|
(7)
|
(6)
|
(7)
|
(7)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
|
| Research & Development |
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(13)
|
(13)
|
(8)
|
(10)
|
(11)
|
(6)
|
(3)
|
(3)
|
(4)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(10)
N/A
|
(12)
-19%
|
(14)
-19%
|
(8)
+42%
|
(8)
-2%
|
(15)
-77%
|
(13)
+10%
|
(10)
+25%
|
(11)
-9%
|
(11)
+0%
|
(7)
+32%
|
(5)
+37%
|
(5)
0%
|
(5)
-17%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(2)
|
7
|
8
|
5
|
2
|
(9)
|
(5)
|
(4)
|
(5)
|
1
|
2
|
0
|
|
| Non-Reccuring Items |
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(11)
N/A
|
(13)
-17%
|
(16)
-26%
|
(1)
+94%
|
(0)
+96%
|
(9)
-20 857%
|
(11)
-20%
|
(19)
-66%
|
(15)
+17%
|
(15)
+3%
|
(12)
+19%
|
(4)
+70%
|
(2)
+35%
|
(5)
-111%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(11)
|
(13)
|
(16)
|
(1)
|
(0)
|
(9)
|
(11)
|
(19)
|
(15)
|
(15)
|
(12)
|
(4)
|
(2)
|
(5)
|
|
| Income to Minority Interest |
1
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(10)
N/A
|
(11)
-13%
|
(14)
-22%
|
(0)
+98%
|
(0)
+84%
|
(9)
-20 857%
|
(11)
-20%
|
(19)
-66%
|
(15)
+17%
|
(15)
+3%
|
(12)
+19%
|
(4)
+70%
|
(2)
+35%
|
(5)
-111%
|
|
| EPS (Diluted) |
-0.07
N/A
|
-0.08
-14%
|
-0.1
-25%
|
0
N/A
|
0.02
N/A
|
-0.04
N/A
|
-0.04
N/A
|
-0.06
-50%
|
-0.05
+17%
|
-0.05
N/A
|
-0.04
+20%
|
-0.01
+75%
|
-0.01
N/A
|
-0.02
-100%
|
|